Review ArticleIndian Journal of Pharmaceutical Education and ResearchVol. 54 | Issue 3 | 2020 | pp. 517–525Open access
Pharm D Program: Is it Necessary in BRICS?
- 1*,
- 2,
- 2,
- 2,
- 1
- 1 College of Pharmacy, Jinan University, Guangzhou, CHINA.
- 2 Faculty of Pharmacy, Rhodes University, Grahamstown, SOUTH AFRICA.
Published in Indian Journal of Pharmaceutical Education and Research
Correspondence: Pei Yu
College of Pharmacy, Jinan University, Guangzhou, CHINA.
Email: pennypeiyu@163.com
Copyright: © 2020 Manuscript Technomedia. This is an open access article.
- Published:
- Jan 1, 2020
- Received:
- Sep 30, 2019
- Accepted:
- Feb 26, 2020
- DOI:
- 10.5530/ijper.54.3.100
How to cite
Yu, P., Wilson, B. J., Bobbins, A. C., Srinivas, S. C., & Yin, G. (2020). Pharm D Program: Is it Necessary in BRICS? Indian Journal of Pharmaceutical Education and Research, 54(3), 517–525. https://doi.org/10.5530/ijper.54.3.100
Abstract
The various trajectories of the development of the Doctor of Pharmacy (Pharm D) programs in BRICS countries were reviewed individually, showing the progress of Pharm D programs in each context. Evidence from developed countries indicates that Pharm D programs have contributed towards the positive development of public health and a country’s local health requirements, with well-trained clinical pharmacists having a key role in the health and economic development of these emerging powers. The health systems of BRICS countries are heavily challenged with a dual burden of disease, weak health infrastructure and public health initiatives. Thus, not only will the development of Pharm D programs in BRICS countries strengthen pharmacy education contributing to a pharmacy workforce more readily able to target health-related problems, demographic and epidemiological shifts; but will also better equip public health systems with more patient-centered pharmaceutical care necessary for evidence-based, individualized and cost-effective healthcare.
Keywords
Subject
Article metadata
| Title | Pharm D Program: Is it Necessary in BRICS? |
|---|---|
| Authors | Pei Yu; Beverley Joy Wilson; Amy Claire Bobbins; Sunitha Chandrasekhar Srinivas; Gang Yin |
| Affiliations | College of Pharmacy, Jinan University, Guangzhou, CHINA.; Faculty of Pharmacy, Rhodes University, Grahamstown, SOUTH AFRICA. |
| Corresponding author | pennypeiyu@163.com |
| Journal | Indian Journal of Pharmaceutical Education and Research |
| Volume / Issue | Vol. 54, Issue 3 (2020) |
Also in this issue
- Is Covid-19 Sibling of SARS and MERS? A Review on: Novel Covid-19pp. 491–495
- Caspase Activators: Phytochemicals with Apoptotic Properties Targeting Cancer, a Health Care Strategy to Combat this Diseasepp. 496–508
- Therapeutic Potential of Chymase Inhibitors in Cardiovascular Diseases: An Overviewpp. 509–516
- Biomaterials in 3D Printing: A Special Emphasis on Nanocellulosepp. 526–540
- Novel Oral Drug Delivery Systems for Steroids: Overview and Recent Updatespp. 541–549